Interleukin-17 signaling influences CD8+ T cell immunity and tumor progression according to the IL-17 receptor subunit expression pattern in cancer cells.
Rodriguez C, Araujo Furlan CL, Tosello Boari J, Bossio SN, Boccardo S, Fozzatti L, Canale FP, Beccaria CG, Nuñez NG, Ceschin DG, Piaggio E, Gruppi A, Montes CL, Acosta Rodríguez EV.
Rodriguez C, et al. Among authors: fozzatti l.
Oncoimmunology. 2023 Oct 5;12(1):2261326. doi: 10.1080/2162402X.2023.2261326. eCollection 2023.
Oncoimmunology. 2023.
PMID: 37808403
Free PMC article.